for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

EMA backs renewing conditional marketing approval for remdesivir in COVID-19 patients

May 21 (Reuters) - Europe’s medicines regulator on Friday recommended to renew the conditional marketing authorization for Gilead Sciences’ remdesivir to treat COVID-19.

Reporting by Vishwadha Chander in Bengaluru; Editing by Anil D’Silva

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up